North American neurological disorder drug is projected to grow at a significant CAGR during the forecast period. The key factors that drive the growth of the market include the rising prevalence of neurological disorders among people across the globe. The rising geriatric population is another major reason for market growth in the North American region. As per the US Census Bureau, in 2010, there were more than 40.3 million US residents of 65 years and older whereas, the count raised to more than 54 million in July 2019. Elder people are more prone to diseases and such neurological disorders, thus creating a wide scope for the North American neurological disorder drugs market. Besides, the launch and innovations of novel products by the key players further supports the growth of the market.
North American neurological disorder drugs market is segmented on the basis of disorder type into Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, Huntington disease, and others. Amongst the disorder type segment, Parkinson’s disease segment is projected to hold a lucrative share in the market. The segmental growth of the market is attributed to the increased prevalence of Parkinson’s disease among people across the globe. A broad range of drugs is used for the treatment of neurological disorders, some of which include analgesics, antihypertensive, anticholinergic, hypnotic & sedatives, and others.
To Request a Free Sample of our North American Neurological Disorder Drugs Market: https://www.omrglobal.com/request-sample/north-american-neurological-disorder-drugs-market
Market Coverage
- Market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
- Segment Covered- By Disorder Type
- Region Covered- North America
- Competitive Landscape- Eli Lilly and Co., Merck & Co. Inc., Allergan Plc., AstraZeneca Plc, Pfizer Inc., Biogen Inc., and Amgen Inc.
North America Neurological Disorder Drugs Market – Segmentation
By Disorder Type
- Alzheimer’s Disease
- Parkinson’s Disease
- Multiple Sclerosis
- Huntington Disease
- Others
A full Report of North American Neurological Disorder Drugs Market is Available at: https://www.omrglobal.com/industry-reports/north-american-neurological-disorder-drugs-market
North America Neurological Disorder Drugs Market – Countries Covered
- US
- Canada
Company Profiles
- AbbVie Inc.
- Overview
- Abbvie Inc. in North America
- Abbvies Inc. in Neurological Disorder Drugs Landscape
- Recent Developments
- ACADIA Pharmaceuticals Inc.
- ApotexInc.
- Allergan Plc
- Amgen Inc.
- AstraZeneca Plc
- Biogen Inc.
- Boehringer Ingelheim International GmbH
- Eli Lilly and Co.
- F. Hoffmann-La Roche Ltd.
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/north-american-neurological-disorder-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
